Skip to Main Content

Pathogenesis of the cardiometabolic risk in youth with type 1 diabetes

Conditions

Diabetes Mellitus - Type 1

What is the purpose of this trial?

Brief Summary:

The purpose of this study is to quantitate hepatic de novo lipogenesis (DNL) in youth with poorly-controlled type 1 diabetes (T1D) (HbA1c >8.5%), youth with T1D who achieve targeted glycemic control (HbA1c <7.5%) and lean controls. Hypothesis: Youth with poor glycemic control experience higher fractional hepatic DNL during the fasting and the postprandial states than youth who achieve targeted glycemic control and lean controls.

  • Trial with
    National Institute of Diabetes and Digestive & Kidney Diseases (NIDDKD)
  • Start Date
    11/19/2019
  • End Date
    03/30/2021
Trial Image

For more information about this study, contact:

Brittany Galuppo

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    12/06/2019
  • Study HIC
    #2000025170